Bronchial hyperresponsiveness, hypersensitivity to analgesics and urinary leukotriene E4 excretion in patients with aspirin-intolerant asthma

International Archives of Allergy and Immunology

Volumn 117, Issue 2, 1998, Pages 146-151

  Yoshida, S ^a,b   Nakagawa, H ^b   Yamawaki, Y ^a   Sakamoto, H ^a   Akahori, K ^c   Nakabayashi, M ^c   Sakamoto, M ^a   Hasegawa, H ^b   Shoji, T ^b   Tajima, T ^b   Amayasu, H ^b,d  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AOKI International Medical Center   (Japan)

^c TOKAI UNIVERSITY   (Japan)

^d YOKOHAMA ROSAI HOSPITAL   (Japan)

Author keywords

Aspirin intolerant asthma; Bronchial hyperresponsiveness; Cromolyn sodium; Leukotriene; Sulpyrine provocation test

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CROMOGLYCATE DISODIUM; DIPYRONE; LEUKOTRIENE E4; METHACHOLINE;

ALLERGIC ASTHMA; ARTICLE; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG HYPERSENSITIVITY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; URINARY EXCRETION;

ADULT; ANTI-ASTHMATIC AGENTS; ASPIRIN; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROMOLYN SODIUM; CROSS-OVER STUDIES; DIPYRONE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEUKOTRIENE E4; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED;

EID: 7844242237     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024002     Document Type: Article

References (28)

1. Houjou S, Dobashi K, Nakazawa T: Aspirin-induced asthma. Jpn J Clin Med 1994;3:355-358.
2. Power I: Aspirin-induced asthma. Br J Anaesth 1993;71:619-621.
3. Szczeklik A, Schmitz SM: Aspirin-induced asthma: From pathogenesis to therapy. Allergol Immunopathol (Madr) 1993;21:35-40.
4. 2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol 1996;98:421-432.
5. Szczeklik A: Aspirin-induced asthma as a viral disease. Clin Allergy 1988;18:15-20.
6. Obata T, Matsuda S, Akasawa A, Iikura Y: Preventive effect and duration of action of disodium cromoglycate and procaterol on exercise-induced asthma in asthmatic children. Ann Allergy 1993;70:123-126.
7. Dahl R: Oral and inhaled sodium cromoglycate in challenge test with food allergens or acetylsalicylic acid. Allergy 1981;36:161-165.
8. Mackay GA, Pearce FL: Extracellular guanosine 3′,5′-cyclic monophosphate and disodium cromoglycate share a similar spectrum of activity in the inhibition of histamine release from isolated mast cells and basophils. Int Arch Allergy Immunol 1996;109:258-265.
9. Leonardi A, Borghesan F, Faggian D, Secchi A, Plebani M: Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjuctivitis. Allergy 1995;50: 610-613.
10. American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary diseases (COPD) and asthma. Am Rev Respir Dis 1987;136:225-244.
11. Chai H, Fair RS, Froehlich LA, Mathison DA, McLean JA, Rosenthal RR, Sheffer AL, Spector SL, Townley RG: Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323-327.
12. Makino S, Kobayashi S, Miyamoto T, Shida T, Takahashi S: Standard for allergen bronchial provocation tests in asthma and hypersensitivity pneumonitis. Jpn J Allergy 1982;31:1074-1076.
13. 4 during aspirin-induced asthma. J Lab Clin Med 1992; 119:48-51.
14. Bagigalupo A, Frassoni F, Van Lint MT: Acyclovir for the treatment of severe aplastic anemia. N Engl J Med 1984;310:1606-1607.
15. Leoni P, Masia C, Offidani M, Da Lio L: Acycloguanosine for the treatment of aplastic anemia. Eur J Haematol 1991;46:120-121.
16. McDonald JR, Mathison DA, Stevenson DD: Aspirin intolerance in asthma. Detection by oral challenge. J Allergy Clin Immunol 1972; 50:198-207.
17. Delaney JC: The diagnosis of aspirin idiosyncrasy by analgesic challenge. Clin Allergy 1976;6:177-181.
18. Spector SL, Wangaard CH, Farr RS: Aspirin and concomitant idiosyncrasies in adult asthmatic patients. J Allergy Clin Immunol 1979;64:500-506.
19. Altpunyan REC: Review of the clinical activity and modes of action of sodium cromoglycate; in Pepys MB, Edwards JH, (eds): The mast cell-it's role in health and disease. London, Pitman Medical. 1979, pp 199-216.
20. Booiji-Noord H, Orie NGM, de Vries K: Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone. J Allergy Clin Immunol 1971;48: 344-348.
21. 4 levels during early and late asthmatic responses. J Allergy Clin Immunol 1990;86:211-220.
22. Hui KP, Taylor IK, Taylor GW, Rubin P, Kesterson J, Barnes NC, Barnes PJ: Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses afer allergen challenge in asthmatic patients Thorax 1991;46: 184-189.
23. Nasser SM, Bell GS, Foster S, Spruce KS, MacMillan R, Williams AJ, Lee TH, Arm JP: Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma. Thorax 1994;49: 749-754.
24. Israel E, Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Shapiro J, Cohn J, Rubin P, Drazen JM: The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis 1993;148:1447-1451. 44:593-601.
25. Israel E, Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Shapiro J, Cohn J, Rubin P, Drazen JM: The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis 1993;148:1447-1451. 44:593-601.
26. Kay AB, Walsh GM, Moqbel R, Mac Donald AJ, Nagakura T, Carroll MP, Richerson HB: Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. J Allergy Clin Immunol 1987;80:1-8.
27. Crimi N, Palermo F, Oliveri R, Vancheri C, Palermo B, Polosa R, Mistretta A: Bronchospasm induced by inhalation of substance P: Effect of sodium chromoglycate. Respiration 1988;54:95-99.
28. Crossman DC, Dashwood MR, Taylor GW, Wellings R, Fuller RW: Sodium cromoglycate: Evidence of tachykinin antagonist activity in the human skin. J Appl Physiol 1993;75:167-172.